BALACYNWYD, Pa., April 23, 2003 (PRIMEZONE) -- Law offices of Brodsky & Smith, LLC today announces that a securities class action lawsuit has been filed on behalf of shareholders who purchased the common stock and other securities of SuperGen, Inc.("SuperGen" or the "Company") (Nasdaq:SUPG) between April 18, 2000 and March 13, 2003, inclusive (the "Class Period").
The case is pending in the United States District Court for the Northern District of California against the company, its Chairman, President and Chief Executive Officer. The complaint charges defendants with violations of the Securities and Exchange Act of 1934, alleging that the defendants issued materially false and misleading statements and failed to disclose certain key information regarding the efficacy and risks associated with its drug MitoExtra(tm). The materially false and misleading statements caused the Company's stock to trade at artificially inflated prices during the Class Period and caused damages to the Class Members.
No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. If you purchased the stock listed above during the Class Period, you have certain rights. To be a member of the class you need not take any action at this time, and you may retain counsel of your choice.
If you were a purchaser of this stock between April 18, 2000 and March 13, 2003 and want to discuss your legal rights, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Marc L. Ackerman, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at clients@brodsky-smith.com, or by calling toll free 877-LEGAL-90.
More information on this and other class actions can be found on the Class Action Newsline at www.primezone.com/ca